Generics - Research


Current filters:


Popular Filters

1 to 25 of 67 results

Mylan starts Ph III trials for generics of Advair Diskus and insulin analog to Lantus


US generic drugs major Mylan says it is initiating Phase III clinical trials for its generic version…

Advair DiskusDiabetesGenericsGlaxoSmithKlineLantusMylanResearchRespiratory and PulmonarySanofi

Indian Pharma increasing capital and research spending

Indian Pharma increasing capital and research spending


With over $50 billion worth of drugs set to go off patent over the next two years in the USA, Indian…

CiplaDr Reddy's LaboratoriesFinancialGenericsGlenmark PharmaceuticalsIndiaLupinMergers & AcquisitionsResearchSun Pharmaceuticals

Amerigen Pharma and Ningbo Menovo link up on generics for US market


US generic drugmaker Amerigen Pharmaceuticals and China’s Ningbo Menovo Pharmaceutical have entered…

Amerigen PharmaceuticalsChinaGenericsNingbo MenovoProductionResearchUSA

Hospira’s Retacrit effective in chemotherapy-induced anemia

Hospira’s Retacrit effective in chemotherapy-induced anemia


USA-based Hospira, a leading provider of generic injectable drugs and infusion technologies, announced…

BiosimilarsErythropoiesis-stimulating agentsGenericsHematologyHospiraInfusion technologiesResearchRetacritUSA

Cipla to invest £100 million in its UK subsidiary

Cipla to invest £100 million in its UK subsidiary


Indian drugmaker Cipla has decided to make a significant investment in its UK subsidiary over the next…

CiplaFinancialGenericsMarkets & MarketingResearchUK

PhRMA slams US President’s claims that Budget invests in innovation


Pharmaceutical Research and Manufacturers of America (PhRMA) president and chief executive John Castellani…

GenericsNorth AmericaPatentsPharmaceuticalPoliticsResearchUSA

Cadila net profit up by 82% in third-quarter


Indian drugmaker Cadila Healthcare posted a net profit of 1.86 billion rupees ($29.7 million), for the…

BiosimilarsCadila PharmaceuticalsFinancialGenericsResearchZydus Cadila

Brazil’s ANVISA and ProGenericos sign cooperation agreement

Brazil’s ANVISA and ProGenericos sign cooperation agreement


Brazil's National Health Surveillance Agency, ANVISA has signed a memorandum of technical and operational…

BiosimilarsBrazilGenericsRegulationResearchSouth America

Kissei and JCR conclude accord on biosimilar Aranesp


Kissei Pharmaceutical and JCR Pharmaceuticals have announced the conclusion of a collaborative R&D agreement…

AmgenAranespAsia-PacificBiosimilarsGenericsJCR PharmaceuticalsKissei PharmaceuticalOncologyResearch

First biosimilar monoclonal antibody approved in Europe


US injectables and infusion technologies firm Hospira (NYSE: HSP) says the European Commission has approved…

Anti-Arthritics/RheumaticsBiotechnologyCellTrionEuropeGenericsHospiraInflectraMerck & CoRemicadeResearch

Baxter and Coherus in up to $246 million deal for biosimilar etanercept


US companies Baxter International (NYSE:BAX) and Coherus Biosciences have entered into an exclusive collaboration…

AmgenAnti-Arthritics/RheumaticsBaxter InternationalBiotechnologyCoherus BioSciencesEnbreletanerceptGenericsLicensingResearch

Teva to drop development of Nuvigil in bipolar 1 disorder


Israel-based leading generics company Teva Pharmaceutical Industries (NYSE: TEVA) has released disappointing…

armodafinilCephalonGenericsNeurologicalNuvigilPharmaceuticalResearchTeva Pharmaceutical Industries

Phase III data support biosimilarity of BOW-015 to Remicade


Privately-held US biotech firm EPIRUS Biopharmaceuticals, which is focused on the development and production…

Anti-Arthritics/RheumaticsBiotechnologyEPIRUS BiopharmaceuticalsGenericsinfliximabRegulationRemicadeResearch

Pharmstandard commits $30 million to Argos Therapeutics; post 1st-half results


Russia's largest drugmaker Pharmstandard (PHST: RU) that its subsidiary Pharmstandard International.(Luxembourg)…

AGS-003Argos TherapeuticsFinancialGenericsOncologyPharmaceuticalPharmstandardResearch

BPH drug doesn't increase risk of death, but does save men from prostate cancer


A long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy & Research…

finasterideGenericsMen's HealthMerck & CoOncologyPharmaceuticalProscarResearch

New lab hopes to attract Western pharma for preclinical studies in Russia


One of Russia's largest laboratories for preclinical studies of drugs will soon be opened in the Vsevologsk…

Dom of PharmacyEuropeGenericsPharmaceuticalResearch

Strategic alliance for pharmaceutical contract research and manufacturing in China


Taiwanese active pharmaceutical ingredients (APIs) maker ScinoPharm (Changshu) Pharmaceuticals (TSE:…

Asia-PacificGenericsProductionResearchScinoPharmSundai MediTech

US firms establish strategic partnership around biosimilars


Privately-held Oncobiologics has formed a broad strategic partnership with fellow USA-based inVentiv…

AvastinBiotechnologyErbituxGenericsHerceptinHumiraImmunologicalsinVentive HealthOncobiologicsOncologyProductionResearchRituxan

Eternity and PharmaNova to develop branded medicines


Canadian medical device company Eternity Healthcare (OTC:ETAH) has signed a letter of intent with privately-held…

Eternity HealthcareGenericsMetabolicsPharmaceuticalPharmaNovaResearch

Indian citizens lack free access to essential generic medicines, while policies risk undermining new drug research funding


Modern India has the third largest national economy in the world in purchasing power adjusted terms.…


Indian pharma threatened by trend of shifting R&D operations overseas: survey


Red tape is putting India's multi-billion dollar worth pharmaceutical industry at risk, with most of…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalRegulationResearch

Prescription painkiller overdoses has risen 400% in women, says the US CDC


Women in the USA are dying from prescription painkiller overdoses at rates never seen before, according…

Endo Health SolutionsGenericsHealthcareMethadoneOpanaOxyContinPurdue PharmaResearchVicodinWomen's Health

Sandoz initiates Ph III trial for biosimilar Enbrel


Swiss drug major Novartis' (NOVN: VX) generics unit Sandoz has initiated a major Phase III clinical trial…


Generics triple-therapy just as effective as brand-name Enbrel, new study shows


Global biotech leader Amgen's (Nasdaq: AMGN) branded drug Enbrel (etanercept) is no more effective in…


1 to 25 of 67 results




Back to top